BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16388420)

  • 1. Thrombotic microangiopathy in transplantation and malignancy.
    Qu L; Kiss JE
    Semin Thromb Hemost; 2005 Dec; 31(6):691-9. PubMed ID: 16388420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment.
    Oran B; Donato M; Aleman A; Hosing C; Korbling M; Detry MA; Wei C; Anderlini P; Popat U; Shpall E; Giralt S; Champlin RE
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):469-77. PubMed ID: 17382253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
    Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
    Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombotic microangiopathy following bone marrow transplantation.
    Pettitt AR; Clark RE
    Bone Marrow Transplant; 1994 Oct; 14(4):495-504. PubMed ID: 7858524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
    Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
    Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Masuda Y; Fujino T; Kaneko T; Utsumi K; Arai T; Ishikawa A; Wakamatsu K; Tajika K; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Jan; 61(1):34-41. PubMed ID: 21166941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
    Shimoni A; Yeshurun M; Hardan I; Avigdor A; Ben-Bassat I; Nagler A
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):484-93. PubMed ID: 15205669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].
    Hirabayashi N
    Rinsho Ketsueki; 2000 Jun; 41(6):491-5. PubMed ID: 10921348
    [No Abstract]   [Full Text] [Related]  

  • 10. Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation.
    Narimatsu H; Kami M; Hara S; Matsumura T; Miyakoshi S; Kusumi E; Kakugawa Y; Kishi Y; Murashige N; Yuji K; Masuoka K; Yoneyama A; Wake A; Morinaga S; Kanda Y; Taniguchi S
    Bone Marrow Transplant; 2005 Sep; 36(6):517-23. PubMed ID: 16025150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.
    Kojouri K; George JN
    Curr Opin Oncol; 2007 Mar; 19(2):148-54. PubMed ID: 17272988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.
    Kennedy GA; Kearey N; Bleakley S; Butler J; Mudie K; Durrant S
    Bone Marrow Transplant; 2010 Apr; 45(4):699-704. PubMed ID: 19767787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease.
    Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y
    Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause.
    Sala E; Neagoie AM; Lewerenz J; Saadati M; Benner A; Gantner A; Wais V; Döhner H; Bunjes D
    Transplant Cell Ther; 2024 Jun; 30(6):586.e1-586.e11. PubMed ID: 38508452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombotic microangiopathy after kidney transplantation].
    Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
    Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?
    Batts ED; Lazarus HM
    Bone Marrow Transplant; 2007 Oct; 40(8):709-19. PubMed ID: 17603513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Mii A; Shimizu A; Kaneko T; Fujita E; Fukui M; Fujino T; Utsumi K; Yamaguchi H; Tajika K; Tsuchiya S; Iino Y; Katayama Y; Fukuda Y
    Pathol Int; 2011 Sep; 61(9):518-27. PubMed ID: 21884301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic microangiopathy after kidney transplantation.
    Ponticelli C; Banfi G
    Transpl Int; 2006 Oct; 19(10):789-94. PubMed ID: 16961769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
    Platzbecker U; von Bonin M; Goekkurt E; Radke J; Binder M; Kiani A; Stoehlmacher J; Schetelig J; Thiede C; Ehninger G; Bornhäuser M
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):101-8. PubMed ID: 19135948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.